Enhabit (NYSE:EHAB – Get Free Report) and First Choice Healthcare Solutions (OTCMKTS:FCHS – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, earnings, profitability, risk and institutional ownership.
Risk and Volatility
Enhabit has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, First Choice Healthcare Solutions has a beta of 0.4, indicating that its stock price is 60% less volatile than the S&P 500.
Earnings & Valuation
This table compares Enhabit and First Choice Healthcare Solutions”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Enhabit | $1.06 billion | 0.66 | -$4.60 million | ($0.09) | -152.72 |
| First Choice Healthcare Solutions | $10,000.00 | 12.20 | -$6.96 million | ($0.20) | -0.02 |
Enhabit has higher revenue and earnings than First Choice Healthcare Solutions. Enhabit is trading at a lower price-to-earnings ratio than First Choice Healthcare Solutions, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Enhabit and First Choice Healthcare Solutions’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Enhabit | -0.43% | 4.71% | 2.23% |
| First Choice Healthcare Solutions | N/A | N/A | -165.98% |
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Enhabit and First Choice Healthcare Solutions, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Enhabit | 1 | 6 | 2 | 0 | 2.11 |
| First Choice Healthcare Solutions | 0 | 0 | 0 | 0 | 0.00 |
Enhabit currently has a consensus target price of $13.57, indicating a potential downside of 1.26%. Given Enhabit’s stronger consensus rating and higher probable upside, equities analysts plainly believe Enhabit is more favorable than First Choice Healthcare Solutions.
Summary
Enhabit beats First Choice Healthcare Solutions on 9 of the 12 factors compared between the two stocks.
About Enhabit
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.
About First Choice Healthcare Solutions
First Choice Healthcare Solutions, Inc. provides healthcare services in the United States. It develops primary care and wellness clinics focused on providing life improvement services, such as anti-aging, weight management, hormone replacement, and pharmacy services. The company is headquartered in Melbourne, Florida.
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.
